150 related articles for article (PubMed ID: 11604225)
1. Tibolone: a compound with tissue specific inhibitory effects on sulfatase.
de Gooyer ME; Kleyn GT; Smits KC; Ederveen AG; Verheul HA; Kloosterboer HJ
Mol Cell Endocrinol; 2001 Oct; 183(1-2):55-62. PubMed ID: 11604225
[TBL] [Abstract][Full Text] [Related]
2. Effect of tibolone (Org OD14) and its metabolites on aromatase and estrone sulfatase activity in human breast adipose stromal cells and in MCF-7 and T47D breast cancer cells.
van de Ven J; Donker GH; Sprong M; Blankenstein MA; Thijssen JH
J Steroid Biochem Mol Biol; 2002 Jul; 81(3):237-47. PubMed ID: 12163135
[TBL] [Abstract][Full Text] [Related]
3. The nature of inhibition of steroid sulphatase activity by tibolone and its metabolites.
Raobaikady B; Day JM; Purohit A; Potter BV; Reed MJ
J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):229-37. PubMed ID: 15862970
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of oestrone sulphatase activity by tibolone and its metabolites.
Purohit A; Malini B; Hooymans C; Newman SP
Horm Metab Res; 2002 Jan; 34(1):1-6. PubMed ID: 11832993
[TBL] [Abstract][Full Text] [Related]
5. Tissue-selectivity: the mechanism of action of tibolone.
Kloosterboer HJ
Maturitas; 2004 Aug; 48 Suppl 1():S30-40. PubMed ID: 15337246
[TBL] [Abstract][Full Text] [Related]
6. Effects of stable transfection of human fetal osteoblast cells with estrogen receptor-alpha on regulation of gene expression by tibolone.
Maran A; Shogren K; Zhang M; Yaszemski MJ; Hefferan TE; Spelsberg TC; Kloosterboer HJ; Turner RT
Bone; 2006 Sep; 39(3):523-9. PubMed ID: 16707283
[TBL] [Abstract][Full Text] [Related]
7. Effect of tibolone (Org OD14) and its metabolites on estrone sulphatase activity in MCF-7 and T-47D mammary cancer cells.
Chetrite G; Kloosterboer HJ; Pasqualini JR
Anticancer Res; 1997; 17(1A):135-40. PubMed ID: 9066643
[TBL] [Abstract][Full Text] [Related]
8. In vivo inhibition of the estrogen sulfatase enzyme and growth of DMBA-induced mammary tumors by melatonin.
González A; Alvarez-García V; Martínez-Campa C; Mediavilla MD; Alonso-González C; Sánchez-Barceló EJ; Cos S
Curr Cancer Drug Targets; 2010 May; 10(3):279-86. PubMed ID: 20370689
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of placental estrone sulfatase activity and MCF-7 breast cancer cell proliferation by estrone-3-amino derivatives.
Selcer KW; Jagannathan S; Rhodes ME; Li PK
J Steroid Biochem Mol Biol; 1996 Sep; 59(1):83-91. PubMed ID: 9009241
[TBL] [Abstract][Full Text] [Related]
10. Tissue-selective effects of tibolone on the breast.
Kloosterboer HJ
Maturitas; 2004 Sep; 49(1):S5-S15. PubMed ID: 15351102
[TBL] [Abstract][Full Text] [Related]
11. Development of potent non-estrogenic estrone sulfatase inhibitors.
Li PK; Chu GH; Guo JP; Peters A; Selcer KW
Steroids; 1998; 63(7-8):425-32. PubMed ID: 9654650
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of steroid sulfatase by an active site-directed inhibitor, estrone-3-O-sulfamate.
Purohit A; Williams GJ; Howarth NM; Potter BV; Reed MJ
Biochemistry; 1995 Sep; 34(36):11508-14. PubMed ID: 7547880
[TBL] [Abstract][Full Text] [Related]
13. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.
Pasqualini JR; Chetrite GS
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):221-36. PubMed ID: 15860265
[TBL] [Abstract][Full Text] [Related]
14. Effects of tibolone on sulfatase pathway of estrogens metabolism and on growth of MCF-7 human breast tumors implanted in ovariectomized nude mice.
Desreux J; Kloosterboer H; Noël A; Frankenne F; Lemaire M; Putman M; Foidart JM
Gynecol Obstet Invest; 2007; 63(1):31-8. PubMed ID: 16899995
[TBL] [Abstract][Full Text] [Related]
15. Tibolone and its delta-4, 7alpha-methyl norethisterone metabolite are reversible inhibitors of human aromatase.
Raobaikady B; Parsons MF; Reed MJ; Purohit A
J Steroid Biochem Mol Biol; 2007 May; 104(3-5):154-60. PubMed ID: 17467267
[TBL] [Abstract][Full Text] [Related]
16. Steroidal oxathiazine inhibitors of estrone sulfatase.
Peters RH; Chao WR; Sato B; Shigeno K; Zaveri NT; Tanabe M
Steroids; 2003 Jan; 68(1):97-110. PubMed ID: 12475726
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological activity of the superestrogen (E)-17-oximino-3-O-sulfamoyl-1,3,5(10)-estratriene: x-ray crystal structure of (E)-17-oximino-3-hydroxy-1,3,5(10)-estratriene.
Hejaz HA; Purohit A; Mahon MF; Reed MJ; Potter BV
J Med Chem; 1999 Aug; 42(16):3188-92. PubMed ID: 10447965
[TBL] [Abstract][Full Text] [Related]
18. Development of (p-O-sulfamoyl)-N-alkanoyl-phenylalkyl amines as non-steroidal estrone sulfatase inhibitors.
Kolli A; Chu GH; Rhodes ME; Inoue K; Selcer KW; Li PK
J Steroid Biochem Mol Biol; 1999 Jan; 68(1-2):31-40. PubMed ID: 10215035
[TBL] [Abstract][Full Text] [Related]
19. Dydrogesterone (Duphaston) and its 20-dihydro-derivative as selective estrogen enzyme modulators in human breast cancer cell lines. Effect on sulfatase and on 17beta-hydroxysteroid dehydrogenase (17beta-HSD) activity.
Chetrite GS; Thole HH; Philippe JC; Pasqualini JR
Anticancer Res; 2004; 24(3a):1433-8. PubMed ID: 15274306
[TBL] [Abstract][Full Text] [Related]
20. Estrone and dehydroepiandrosterone sulfatase activities in normal and pathological human endometrium biopsies.
Prost O; Adessi GL
J Clin Endocrinol Metab; 1983 Apr; 56(4):653-61. PubMed ID: 6220025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
